Results 51 to 60 of about 13,742 (189)
International Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 759-771, February 2026.Abstract Background The introduction of immunoglobulin G (IgG) anti‐D prophylaxis for Rhesus D (RhD)‐negative women has substantially reduced the incidence of RhD alloimmunization and hemolytic disease of the fetus and newborn in Europe by 85%, transforming fetal health outcomes.
Kristina Gemzell‐Danielsson +11 more
wiley +1 more source
Women's Health ReportsBackground: About 25% of pregnancies end in early miscarriage or abortion annually in the United States. While mifepristone is part of the most effective medication regimen for miscarriage and abortion, regulatory burdens and legal restrictions limit its
Emily Newton-Hoe +4 more
doaj +1 more source
The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy. [PDF]
PLoS ONE, 2018 The abortifacient Mifepristone (RU486) has proven to be a safe, effective, acceptable option for millions of women seeking abortion during the first and second trimester of pregnancy although its precise mechanism of action is not well understood.
Adrienn Lajko +3 more
doaj +1 more source
Outcomes of medical management of miscarriage in an early pregnancy setting
International Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 1023-1031, February 2026.Abstract Objective Miscarriage is the most common complication of pregnancy. Medical management with misoprostol offers an alternative to surgical intervention. The aim of this study was to evaluate the outcomes of medical management of first‐trimester miscarriage in the setting of an early pregnancy unit at a tertiary maternity hospital.
S. Elsayed +5 more
wiley +1 more source
Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing’s Syndrome
Case Reports in Endocrinology, 2016 A 30-year-old Caucasian man presented with severe Cushing’s syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor.
Andreas G. Moraitis, Richard J. Auchus
doaj +1 more source
ALTERNATIVE APPROACHES TO MEDICAL ABORTION [PDF]
Trakia Journal of SciencesMedical abortion involving various pharmacological agents has demonstrated high levels of complete uterine evacuation. Alternative approaches involving letrozole, mifepristone, methotrexate used synergically with misoprostol are non-invasive elective ...
K. Telbiyska, M. Angelova
doaj +1 more source
Advanced Science, Volume 13, Issue 4, 19 January 2026.This study demonstrates that bisphenol analogues, particularly BPAF, bind to progesterone receptor, promoting breast cancer cell proliferation, migration, and mammary tumor growth, indicating that bisphenol A substitutes may pose equal or greater health risks.
Xiaotong Ji +8 more
wiley +1 more source
Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
International Journal of Women's Health, 2013 Josep Lluis Carbonell Esteve,1 Rita Acosta,2 Yasmirian Pérez,2 Barbara Rodriguez,2 Isabel Seigler,2 Carlos Sanchez,2 Giuseppe Tomasi3 1Mediterránea Médica Clinic, Valencia, Spain; 2Eusebio Hernández Gynecology and Obstetrics ...
Esteve Carbonell JL +6 more
doaj
Advanced Science, Volume 13, Issue 2, 9 January 2026.Natural killer cells, central to anti‐tumor defense, undergo unexpected reprogramming within the tumor microenvironment. Instead of producing IFN‐γ and TNF‐α, they elevate amphiregulin, a tumor‐promoting factor. This shift is linked to glucocorticoid receptor activity and prostaglandin signaling.
Qin Wei +8 more
wiley +1 more source
Reproductive outcomes following surgical removal of uterine fibroids
Медицинский совет, 2019 The cohort prospective comparative study investigated the efficacy of mifepristone use in patients after surgical treatment of uterine myoma. It was shown that the use of mifepristone at a dose of 50 mg/day in a continuous mode for 3 months after ...
A. E. Mitichkin +7 more
doaj +1 more source